ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
Fewer renal complications seen with tirzepatide versus insulin glargine in adults with T2D and increased cardiovascular risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.